Name: Soleno Therapeutics, Inc. (SLNO) Balance Sheet
Creator: FinSpry

Soleno Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Soleno Therapeutics, Inc. (SLNO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	87.93	169.68	14.60	21.30	49.22	20.73	24.08
Short-Term Investments	203.51	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	291.44	169.68	14.60	21.30	49.22	20.73	24.08
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.06
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.45	1.68	1.05	1.12	1.02	6.96	0.00
Total Current Assets	293.89	171.36	15.65	22.42	50.24	21.14	24.67
Non-Current Assets
Property, Plant & Equipment (Net)	2.98	0.42	0.16	0.45	0.16	0.40	0.01
Long-Term Investments	27.21	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	6.81	8.75	10.69	12.64	14.58	0.00	0.00
Other Non-Current Assets	0.08	0.17	0.00	0.04	0.00	0.08	0.00
Total Non-Current Assets	37.08	9.33	10.85	13.13	14.74	17.01	18.48
Total Assets	330.97	180.69	26.50	35.55	64.98	38.17	43.15
Current Liabilities
Accounts Payable	8.88	3.15	1.78	3.25	3.49	2.28	1.25
Short-Term Debt	0.53	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	1.83	6.53	3.22	3.42	4.79	0.00	0.00
Other Current Liabilities	2.74	1.56	0.48	0.32	0.19	2.38	0.35
Total Current Liabilities	18.75	11.51	7.31	8.01	8.62	4.96	1.88
Non-Current Liabilities
Long-Term Debt	49.83	0.13	0.00	0.18	0.00	0.00	0.00
Other Non-Current Liabilities	14.81	11.55	8.84	9.55	10.82	0.15	5.65
Total Non-Current Liabilities	67.11	15.07	8.84	9.75	14.07	6.09	10.86
Total Liabilities	85.86	23.18	16.15	17.76	19.44	23.23	12.74
Stockholders' Equity
Common Stock	0.05	0.03	0.01	0.08	0.08	0.00	0.00
Retained Earnings	-452.26	-276.41	-237.42	-213.36	-182.45	-157.81	-127.03
Accumulated Other Comprehensive Income	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	696.97	433.89	247.76	231.07	227.91	172.71	157.41
Shares Outstanding	45.70	31.68	8.16	5.32	0.00	0.00	0.00
Total Stockholders' Equity	245.11	157.51	10.35	17.79	45.55	14.95	30.41
Total Liabilities & Equity	330.97	180.69	26.50	35.55	64.98	38.17	43.15